The Anaesthesia & Respiratory Devices Market size in the Middle East & Africa was worth USD 1.85 billion in 2020. It is further estimated to be growing at a CAGR of 8.74% and worth USD 2.81 billion by 2025.
Procuring refurbished anesthesia equipment has been a significantly noticeable trend among several healthcare organizations, clinics, and outpatient surgery centers. The familiarity of anesthetists with a specific machine due to years of proficiency in using it and longer waiting periods for new equipment to be delivered are factors that have opened the gates for refurbishes to enter the anesthesia equipment marketplace.
The increasing base of geriatric population and rising rates of environmental pollution also leads to these devices' growth. Moreover, patients' shifting preference towards home care devices from hospital care is also expected to accelerate the demand for anesthesia and respiratory devices market over the forecast period.
However, the high costs associated with products, strict regulatory approvals, and alternate medications are the key restraints for the market.
This research report on the Middle East and Africa Anaesthesia and Respiratory Devices Market segmented and sub-segmented into the following categories.
By Device:
By Region:
Leading healthcare companies like Philips Healthcare, OSI Systems, Mindray, GE Healthcare, Draegerwerk AG, Masimo, Getinge Group, Fisher and Paykel, Covidien, Airsep Corp, Alung Technologies Inc, Bomimed Inc, 3M, Carefusion Inc, Astra Zeneca, Invacare, ResMed, Teleflex Inc, and Smiths Medical are playing an important role in the Anaesthesia and Respiratory Devices Market in the Middle East & Africa region.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Device
5.1.1 Introduction
5.1.2 Anaesthesia Devices
5.1.2.1 Anaesthesia Machines
5.1.2.2 Anaesthetic Monitors
5.1.2.3 Anaesthetic Vaporizers
5.1.2.4 Analgesic Machines
5.1.2.5 Anaesthetic Masks
5.1.2.6 Anaesthetic Accessories
5.1.3 Respiratory Devices
5.1.3.1 Humidifiers
5.1.3.2 Resuscitators
5.1.3.3 Breathing Circuits
5.1.3.4 Chambers
5.1.3.5 CPAP Devices
5.1.3.6 Masks
5.1.3.7 Oxygen Concentrators
5.1.3.8 Nebulizers
5.1.3.9 Ventilators
5.1.3.10 Inhalers
5.1.3.11 Tracheotomy Tubes
5.1.3.12 Oxygen Cannula
5.1.3.13 Capnographs
5.1.3.14 Spirometers
5.1.5 Y-o-Y Growth Analysis, By Device
5.1.6 Market Attractiveness Analysis, By Device
5.1.7 Market Share Analysis, By Device
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Device
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Device
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Philips Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 OSI Systems and Mindray
8.3 GE Healthcare
8.4 Draegerwerk AG
8.5 Masimo
8.6 Getinge Group
8.7 Fisher and Paykel
8.8 Covidien
8.9 Airsep Corp.
8.10 Alung Technologies Inc.
8.11 Bomimed Inc.
8.12 3M
8.13 Carefusion Inc.
8.14 Astra Zeneca
8.15 Invacare
8.16 ResMed
8.17 Teleflex Inc.
8.18 Smiths Medical
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
